Steven John Heilbron
First SEC filing: Jan. 2, 2025 · Latest: Jan. 2, 2025
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2025 | LSAK | A | 150,000 | · | · | 150,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 2, 2025 | LSAK | A | 150,000 | · | · | 150,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 2, 2025 | LSAK | A | 100,000 | · | · | 350,000 Direct | +40.00% | Acquired | (price as of 2026-10-05) |
| Dec. 31, 2024 | LSAK | A | 250,000 | · | · | 250,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Dec. 31, 2024 | LSAK | A | 350,000 | · | · | 350,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Oct. 25, 2023 | LSAK | A | 225,000 | · | · | 750,000 Direct | +42.86% | Acquired | (price as of 2026-10-05) |
| Dec. 31, 2022 | LSAK | A | 225,000 | · | · | 525,000 Direct | +75.00% | Acquired | (price as of 2026-10-05) |
| Dec. 31, 2022 | LSAK | A | 300,000 | · | · | 300,000 Direct | · | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 2, 2025 | LSAK | Employee stock option (right to buy) | Common stock | $14.00 | Jan. 31, 2029 | 150,000 | Acquired |
| Jan. 2, 2025 | LSAK | Employee stock option (right to buy) | Common stock | $11.00 | Jan. 31, 2029 | 150,000 | Acquired |
| Jan. 2, 2025 | LSAK | Employee stock option (right to buy) | Common stock | $8.00 | Jan. 31, 2029 | 100,000 | Acquired |
| Dec. 31, 2024 | LSAK | Employee stock option (right to buy) | Common stock | $8.00 | Jan. 31, 2029 | 250,000 | Acquired |
| Dec. 31, 2024 | LSAK | Employee stock option (right to buy) | Common stock | $6.00 | Jan. 31, 2029 | 350,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $391,667 | · | · | · | $240,000 | · | · | $1,473,667 |
| 2024 | $350,000 | $72,366 | · | · | $327,634 | · | · | $1,733,250 |
| 2023 | $296,682 | · | · | · | $318,185 | · | · | $3,003,617 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.